Plain-English translation of NCT06974279 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study uses a technique called transcranial magnetic stimulation (TMS) — a non-invasive way to stimulate specific areas of the brain — combined with speech therapy to help stroke survivors regain language and naming abilities. Researchers will use brain imaging to identify the best spot in your brain to stimulate, then compare whether targeting that precise location works better than stimulating a control location.
Many stroke survivors struggle with aphasia, a condition that makes it hard to speak or find words. While speech therapy helps, this treatment aims to boost recovery by combining therapy with targeted brain stimulation to 'wake up' language areas of the brain.
You likely qualify if…
You likely don't qualify if…
You would receive sessions combining TMS (a magnetic coil held against your scalp for about 20–30 minutes) with speech therapy. Half of participants will receive stimulation at a precision-targeted brain location, while the other half receive stimulation at a control location. The main measure of success will be how well you can name pictures before and after the treatment.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States
Enrollment target
~50 participants
Started
September 2025
Primary completion
December 2036
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sidney Schoenrock, MA
Medical College of Wisconsin
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.